GMO U.S. Value ETF (NYSEARCA:GMOV) Short Interest Up 219.0% in June

GMO U.S. Value ETF (NYSEARCA:GMOV) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 13,609 shares, a growth of 219.0% from the May 31st total of 4,266 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average daily volume of 16,719 shares, the short-interest ratio is currently 0.8 days.

GMO U.S. Value ETF Stock Performance

Shares of GMO U.S. Value ETF stock opened at $30.14 on Tuesday. GMO U.S. Value ETF has a 1 year low of $24.79 and a 1 year high of $30.57. The firm’s 50-day simple moving average is $29.85 and its 200-day simple moving average is $28.89. The firm has a market cap of $87.41 million, a PE ratio of 12.08 and a beta of 0.64.

Institutional Trading of GMO U.S. Value ETF

Hedge funds and other institutional investors have recently bought and sold shares of the company. RPS Advisory Solutions LLC bought a new position in GMO U.S. Value ETF during the 4th quarter worth approximately $484,000. Legacy Capital Wealth Partners LLC increased its holdings in shares of GMO U.S. Value ETF by 6.8% in the 4th quarter. Legacy Capital Wealth Partners LLC now owns 96,504 shares of the company’s stock valued at $2,653,000 after acquiring an additional 6,156 shares during the last quarter. MML Investors Services LLC bought a new stake in shares of GMO U.S. Value ETF in the 4th quarter valued at approximately $1,794,000. StoneX Group Inc. acquired a new stake in shares of GMO U.S. Value ETF during the 4th quarter valued at approximately $1,536,000. Finally, Fund Evaluation Group LLC raised its position in shares of GMO U.S. Value ETF by 7.4% during the 4th quarter. Fund Evaluation Group LLC now owns 50,500 shares of the company’s stock valued at $1,388,000 after acquiring an additional 3,500 shares in the last quarter.

GMO U.S. Value ETF Company Profile

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.